We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Oncolytic adenovirus modified with somatostatin motifs for selective infection of neuroendocrine tumor cells.
- Authors
Leja, J; Yu, D; Nilsson, B; Gedda, L; Zieba, A; Hakkarainen, T; Åkerström, G; Öberg, K; Giandomenico, V; Essand, M
- Abstract
We have previously described the oncolytic adenovirus, Ad(CgA-E1A-miR122), herein denoted Ad5(CgA-E1A-miR122) that selectively replicates in and kills neuroendocrine cells, including freshly isolated midgut carcinoid cells from liver metastases. Ad5(CgA-E1A-miR122) is based on human adenovirus serotype 5 (Ad5) and infects target cells by binding to the coxsackie-adenovirus receptor (CAR) and integrins on the cell surface. Some neuroendocrine tumor (NET) and neuroblastoma cells express low levels of CAR and are therefore poorly transduced by Ad5. However, they often express high levels of somatostatin receptors (SSTRs). Therefore, we introduced cyclic peptides, which contain four amino acids (FWKT) and mimic the binding site for SSTRs in the virus fiber knob. We show that FWKT-modified Ad5 binds to SSTR₂ on NET cells and transduces midgut carcinoid cells from liver metastases about 3-4 times better than non-modified Ad5. Moreover, FWKT-modified Ad5 overcomes neutralization in an ex vivo human blood loop model to greater extent than Ad5, indicating that fiber knob modification may prolong the systemic circulation time. We conclude that modification of adenovirus with the FWKT motif may be beneficial for NET therapy.
- Publication
Gene therapy, 2011, Vol 18, Issue 11, p1052
- ISSN
1476-5462
- Publication type
Journal Article
- DOI
10.1038/gt.2011.54